MAXIMUS, Inc. (NYSE:MMS) Expected to Announce Quarterly Sales of $804.28 Million

Analysts expect MAXIMUS, Inc. (NYSE:MMS) to post sales of $804.28 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for MAXIMUS’s earnings, with the highest sales estimate coming in at $814.63 million and the lowest estimate coming in at $793.12 million. MAXIMUS posted sales of $664.62 million during the same quarter last year, which suggests a positive year over year growth rate of 21%. The company is expected to announce its next earnings results on Thursday, February 6th.

On average, analysts expect that MAXIMUS will report full-year sales of $3.23 billion for the current year, with estimates ranging from $3.20 billion to $3.26 billion. For the next fiscal year, analysts expect that the firm will post sales of $2.99 billion, with estimates ranging from $2.95 billion to $3.07 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow MAXIMUS.

MAXIMUS (NYSE:MMS) last released its quarterly earnings data on Tuesday, November 19th. The health services provider reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.01). The company had revenue of $754.97 million for the quarter, compared to analyst estimates of $756.40 million. MAXIMUS had a return on equity of 21.09% and a net margin of 8.34%. The firm’s revenue for the quarter was up 35.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.71 EPS.

A number of brokerages have recently commented on MMS. ValuEngine raised shares of MAXIMUS from a “sell” rating to a “hold” rating in a report on Friday, October 25th. Canaccord Genuity lifted their target price on shares of MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a report on Tuesday, August 13th.

Shares of MAXIMUS stock opened at $73.44 on Wednesday. The firm’s fifty day simple moving average is $75.47 and its 200-day simple moving average is $75.28. The stock has a market capitalization of $4.77 billion, a price-to-earnings ratio of 19.74, a PEG ratio of 1.84 and a beta of 0.79. MAXIMUS has a 12 month low of $62.00 and a 12 month high of $82.02.

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a $0.28 dividend. This is a boost from MAXIMUS’s previous quarterly dividend of $0.25. This represents a $1.12 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend was Thursday, November 14th. MAXIMUS’s payout ratio is currently 30.11%.

In other MAXIMUS news, Director Raymond B. Ruddy sold 25,000 shares of the business’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $79.89, for a total transaction of $1,997,250.00. Following the sale, the director now directly owns 156,852 shares in the company, valued at approximately $12,530,906.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Richard A. Montoni sold 11,000 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $80.40, for a total transaction of $884,400.00. Following the sale, the insider now owns 337,874 shares in the company, valued at $27,165,069.60. The disclosure for this sale can be found here. Insiders sold a total of 43,496 shares of company stock worth $3,462,095 over the last three months. 2.20% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Allianz Asset Management GmbH boosted its position in shares of MAXIMUS by 12.3% during the 2nd quarter. Allianz Asset Management GmbH now owns 329,750 shares of the health services provider’s stock worth $23,920,000 after purchasing an additional 36,225 shares in the last quarter. Strs Ohio boosted its position in shares of MAXIMUS by 7.5% during the 2nd quarter. Strs Ohio now owns 10,000 shares of the health services provider’s stock worth $725,000 after purchasing an additional 700 shares in the last quarter. Tygh Capital Management Inc. purchased a new stake in shares of MAXIMUS during the 3rd quarter worth $6,202,000. Amundi Pioneer Asset Management Inc. boosted its position in shares of MAXIMUS by 13.6% during the 2nd quarter. Amundi Pioneer Asset Management Inc. now owns 168,969 shares of the health services provider’s stock worth $89,411,000 after purchasing an additional 20,289 shares in the last quarter. Finally, P2 Capital Partners LLC boosted its position in shares of MAXIMUS by 1.0% during the 2nd quarter. P2 Capital Partners LLC now owns 1,083,594 shares of the health services provider’s stock worth $78,604,000 after purchasing an additional 11,000 shares in the last quarter. Institutional investors own 94.70% of the company’s stock.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Article: Trading Strategy

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.